CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | DeGolyer Donald W Director | Sale | −7,844 | $8.65 | $68K | 137,659 |
| 2025-07-11 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −4,263 | $7.36 | $31K | 103,692 |
| 2025-06-08 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −1,167 | $6.63 | $8K | 107,955 |
| 2025-06-08 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −1,249 | $6.63 | $8K | 174,927 |
| 2025-06-08 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −464 | $6.63 | $3K | 85,871 |
| 2025-06-08 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −2,733 | $6.63 | $18K | 296,492 |
| 2025-05-23 | Katkin Keith Director | Sale 10b5-1 | −7,844 | $6.30 | $49K | 86,431 |
| 2025-05-13 | PAPA JOSEPH C President and CEO | Purchase | +60,000 | $5.83 | $350K | 342,500 |
| 2025-05-07 | LINDAHL RICHARD S EVP, Chief Financial Officer | Other disposition · Employee Stock Option (Right to buy) | −19,963 | 0 | ||
| 2025-04-30 | Richard Ronald Director | Grant or award | +34,403 | 105,517 | ||
| 2025-04-30 | Richard Ronald Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | White Marvin L Director | Grant or award | +34,403 | 88,495 | ||
| 2025-04-30 | White Marvin L Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | Fowler Neal Franklin Director | Grant or award | +34,403 | 135,503 | ||
| 2025-04-30 | Fowler Neal Franklin Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | Zoon Kathryn C Director | Grant or award | +34,403 | 78,885 | ||
| 2025-04-30 | Zoon Kathryn C Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | Dayal Sujata Tyagi Director | Grant or award | +34,403 | 97,532 | ||
| 2025-04-30 | Dayal Sujata Tyagi Director | Grant or award · Stock Option (Right to Buy) | +15,824 | 41,572 | ||
| 2025-04-30 | Katkin Keith Director | Grant or award | +34,403 | 94,275 |
Page 5 of 17 · 330 trades